Responses
Poster Presentations
Rheumatoid arthritis - anti-TNF therapy
SAT0169 Maintenance and improvement in clinical efficacy between week 12 and 24 in patients with rheumatoid arthritis treated with sb4 or reference etanercept
Compose a Response to This Article
Other responses
No responses have been published for this article.